ASHLEY ZIMMERMAN: Open Payments
NPI 1407140999 · BRASELTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,218 in 65 payments from 14 companies in 2025. Trend: 2023 $808 · 2024 $1,057 · 2025 $1,218
Food & beverage: $1,218
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 12 | $338 |
| ABBVIE INC. | 29 | $330 |
| ARGENX US, INC. | 4 | $99 |
| Kedrion Biopharma, Inc. | 3 | $71 |
| Biogen, Inc. | 3 | $69 |
| SK Life Science, Inc. | 2 | $68 |
| Lundbeck LLC | 3 | $66 |
| PFIZER INC. | 2 | $41 |
| Amneal Pharmaceuticals LLC | 2 | $33 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
Products named: QULIPTA, Fintepla, UBRELVY, Briviact, Nayzilam, Albuked, SKYCLARYS, BOTOX.
Industry payments across GA — which companies pay providers there.
